Biyun Tian
Biyun Tian was founded in 2001 by international students working and studying at Harvard University. For over 20 years, we have been dedicated to independent research and development as well as production. Established in 2007, Shanghai Biyuntian Biotechnology Co., Ltd. is a national level specialized, refined, unique, and new "Little Giant" enterprise. It was further selected as one of the second batch of national level specialized, refined, unique, and new "Little Giant" enterprises recommended for support in the first year. It is also a Shanghai Science and Technology Little Giant Enterprise, a leading enterprise in the G60 Science and Technology Innovation Corridor, one of the top 100 private enterprises driving science and technology innovation in the Yangtze River Delta G60 Science and Technology Innovation Corridor, a "TOP100" brand value list for Shanghai specialized, refined, unique, and new "Little Giant" enterprises, a Shanghai specialized, refined, unique, and new small and medium-sized enterprise, and a Shanghai high-tech enterprise. It is also an executive director unit of the China Inspection and Testing Society and a director unit of the Scientific Research Reagent Branch of the. The company mainly develops and produces reagents, test kits, consumables, and equipment for biological and medical research, while providing technical services for life science research and a one-stop platform for purchasing experimental instruments and equipment
Recommended Posts
-
Cancer cells are very "cunning", they will use immune checkpoints to conceal their "bad person identity" - the proteins expressed on the surface of tumor cells will bind to the proteins on the surface of T cells, sending a signal to the immune system to "own people, don't kill me", thus avoiding the detection and attack of immune cells.Based on this principle, scientists have developed antibodies that block binding, namely immune checkpoint inhibitors, to achieve anti-cancer goals by releasing T cells. So far, the FDA has approved six immune checkpoint inhibitors targeting pathways, suitable for various cancers such as melanoma, non-small cell lung cancer, and renal cell carcinoma. -
Researchers have found that their appendix tissue has protein clusters similar to those observed in the brains of Parkinson's disease patients. This discovery suggests that the appendix plays a role in the early stages of this disease by aggregating these same proteins. These proteins contribute to Parkinson's disease in some way, so appendectomy may prevent their harmful activity. Researchers have found that their appendix tissue has protein clusters similar to those observed in the brains of Parkinson's disease patients. This discovery suggests that the appendix plays a role in the early stages of this disease by aggregating these same proteins. These proteins contribute to Parkinson's disease in some way, so appendectomy may prevent their harmful activity.
-
Under the trend of domestic substitution in the medical device industry, the drive to explore overseas markets is also increasing. Going global is the key for the medical device industry to seek new growth curves and enhance international competitiveness.Moreover, China is implementing a more proactive opening-up strategy. Jointly building the "the Belt and Road" has become a popular international public product and international cooperation platform to achieve higher quality and deeper mutual benefit and win-win results with countries along the line.
